FAHD1

Across TCGA pan-cancer cohorts, FAHD1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated FAHD1 data layer compared with 26 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher FAHD1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated FAHD1 expression acts as an unfavorable survival marker, although some lineages such as PDAC and LSCC show a favorable association.

PDAC, LUAD, and UCEC are the cancer types where FAHD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	All	0.682	0.472	.010	20	view →
LUAD	DFS	Median	II,III,IV	0.721	0.937	.007	9	view →
UCEC	DFS	Median	All	0.936	1.000	.023	6	view →
LSCC	DFS	Median	II,III,IV	0.883	0.662	.018	6	view →
CCRCC	DFS	Median	All	0.656	0.840	.042	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

FAHD1–PDAC (OS)

Open the PDAC breakdown →